Application of a Combination of Alteplase and Dabigatran in Pulmonary Artery Thromboembolism
The results of this study confirmed the efficacy and safety of systemic thrombolytic therapy with alteplase followed by dabigatran without previous heparin therapy in patients with pulmonary artery thromboembolism. This combination can be considered as a method of treatment and prevention of this disease.